MUC16 is a high‐molecular‐weight glycoprotein that is expressed by the various epithelial
cell surfaces of the human body to protect the cell layer from a myriad of insults. It is the …

Epithelial ovarian cancer constitutes one-quarter of the gynecologic malignancies, but is the
leading cause of death among women with gynecologic cancer. In 60-70% of the women …

BACKGROUND Human epididymis protein 4 (HE4), a precursor of human epididymis
protein, has been proposed as a tumor marker for ovarian cancer. We evaluated HE4 in …

Rationale: We have previously identified six serum tumor markers (TMs)(carcinoembryonic
antigen, carbohydrate antigen 15.3, squamous cell carcinoma–associated antigen …

The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125
and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients …

Background: Tumor markers have been extensively studied in lung cancer, reporting some
relationship to the histology, but their clinical utility is not clear. Methods: ProGRP, CEA …

Tumor marker serum levels were prospectively studied in 289 patients with suspected, but
unconfirmed, lung cancer and in 513 patients with lung cancer [417 non-small cell lung …

Ascites is a common complication of cirrhosis. The development of ascites marks the onset
of worsened prognosis and increased mortality in patients with cirrhosis. Ascites also causes …

AIMS--To investigate the secretion of the tumour marker CA 125 by cultured human
mesothelial cells; to determine if secretion of CA 125 could be observed by activating the …

Cholestatic liver fibrosis is caused by obstruction of the biliary tract and is associated with
early activation of portal fibroblasts (PFs) that express Thy-1, fibulin 2, and the recently …